1. Home
  2. AYTU vs AIHS Comparison

AYTU vs AIHS Comparison

Compare AYTU & AIHS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • AIHS
  • Stock Information
  • Founded
  • AYTU N/A
  • AIHS 2014
  • Country
  • AYTU United States
  • AIHS China
  • Employees
  • AYTU N/A
  • AIHS N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • AIHS Finance: Consumer Services
  • Sector
  • AYTU Health Care
  • AIHS Finance
  • Exchange
  • AYTU Nasdaq
  • AIHS Nasdaq
  • Market Cap
  • AYTU 9.8M
  • AIHS 9.7M
  • IPO Year
  • AYTU N/A
  • AIHS 2018
  • Fundamental
  • Price
  • AYTU $1.38
  • AIHS $0.90
  • Analyst Decision
  • AYTU
  • AIHS
  • Analyst Count
  • AYTU 0
  • AIHS 0
  • Target Price
  • AYTU N/A
  • AIHS N/A
  • AVG Volume (30 Days)
  • AYTU 37.2K
  • AIHS 8.0K
  • Earning Date
  • AYTU 02-12-2025
  • AIHS 02-07-2025
  • Dividend Yield
  • AYTU N/A
  • AIHS N/A
  • EPS Growth
  • AYTU N/A
  • AIHS N/A
  • EPS
  • AYTU N/A
  • AIHS N/A
  • Revenue
  • AYTU $79,759,000.00
  • AIHS $6,067,071.00
  • Revenue This Year
  • AYTU N/A
  • AIHS N/A
  • Revenue Next Year
  • AYTU N/A
  • AIHS N/A
  • P/E Ratio
  • AYTU N/A
  • AIHS N/A
  • Revenue Growth
  • AYTU N/A
  • AIHS 3.33
  • 52 Week Low
  • AYTU $1.30
  • AIHS $0.38
  • 52 Week High
  • AYTU $3.45
  • AIHS $1.45
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 33.90
  • AIHS 49.20
  • Support Level
  • AYTU $1.30
  • AIHS $0.87
  • Resistance Level
  • AYTU $1.47
  • AIHS $0.93
  • Average True Range (ATR)
  • AYTU 0.12
  • AIHS 0.04
  • MACD
  • AYTU -0.01
  • AIHS 0.00
  • Stochastic Oscillator
  • AYTU 17.78
  • AIHS 53.71

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About AIHS Senmiao Technology Limited

Senmiao Technology Ltd is a holding company. The company's operating segment includes Automobile Transaction and Related Services focusing on the online ride-hailing industry in the People's Republic of China and Online ride-hailing platform Services through its own platform, Xixingtianxia. It generates maximum revenue from the Automobile Transaction and Related Services segment. Geographically, it derives revenue from China.

Share on Social Networks: